tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Apollomics, LaunXP enter development, commercial agreement for Vebreltinib
PremiumThe FlyApollomics, LaunXP enter development, commercial agreement for Vebreltinib
6M ago
Apollomics announces results from Phase 3 bridging trial of uproleselan
Premium
The Fly
Apollomics announces results from Phase 3 bridging trial of uproleselan
9M ago
Apollomics Inc trading resumes
Premium
The Fly
Apollomics Inc trading resumes
10M ago
Upcoming Stock Splits This Week (November 25 to November 29) – Stay Invested
PremiumMarket NewsUpcoming Stock Splits This Week (November 25 to November 29) – Stay Invested
10M ago
Apollomics Inc trading halted, news pending
Premium
The Fly
Apollomics Inc trading halted, news pending
10M ago
Apollomics announces approval, date for 1-for-100 reverse share split
Premium
The Fly
Apollomics announces approval, date for 1-for-100 reverse share split
10M ago
Apollomics price target lowered to $2 from $5 at H.C. Wainwright
PremiumThe FlyApollomics price target lowered to $2 from $5 at H.C. Wainwright
1y ago
Apollomics announces approval of vebreltinib in China
Premium
The Fly
Apollomics announces approval of vebreltinib in China
1y ago
Apollomics presents vebreltinib data at AACR meeting
Premium
The Fly
Apollomics presents vebreltinib data at AACR meeting
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100